Annual ROE
55.77%
-24.54%-30.56%
December 31, 2023
Summary
- As of February 7, 2025, MED annual return on equity is 55.77%, with the most recent change of -24.54% (-30.56%) on December 31, 2023.
- During the last 3 years, MED annual ROE has fallen by -22.73% (-28.96%).
- MED annual ROE is now -78.66% below its all-time high of 261.38%, reached on December 31, 2000.
Performance
MED ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
3.60%
-11.12%-75.54%
September 30, 2024
Summary
- As of February 7, 2025, MED quarterly return on equity is 3.60%, with the most recent change of -11.12% (-75.54%) on September 30, 2024.
- Over the past year, MED quarterly ROE has dropped by -11.12% (-75.54%).
- MED quarterly ROE is now -97.50% below its all-time high of 143.74%, reached on December 31, 2000.
Performance
MED Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MED ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.6% | -75.5% |
| 3 y3 years | -29.0% | -96.1% |
| 5 y5 years | +8.8% | -94.3% |
MED ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.9% | at low | -95.9% | at low |
| 5 y | 5-year | -38.9% | at low | -96.3% | at low |
| alltime | all time | -78.7% | +116.9% | -97.5% | +145.9% |
Medifast ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 3.60%(-75.5%) |
| Jun 2024 | - | 14.72%(-58.2%) |
| Mar 2024 | - | 35.22%(-35.8%) |
| Dec 2023 | 55.77%(-30.6%) | 54.86%(-21.8%) |
| Sep 2023 | - | 70.11%(-16.5%) |
| Jun 2023 | - | 83.97%(-2.6%) |
| Mar 2023 | - | 86.23%(+2.5%) |
| Dec 2022 | 80.31%(-11.9%) | 84.10%(-0.4%) |
| Sep 2022 | - | 84.42%(+1.0%) |
| Jun 2022 | - | 83.55%(-0.2%) |
| Mar 2022 | - | 83.69%(-5.6%) |
| Dec 2021 | 91.20%(+16.2%) | 88.61%(-3.2%) |
| Sep 2021 | - | 91.53%(-4.7%) |
| Jun 2021 | - | 96.02%(+7.1%) |
| Mar 2021 | - | 89.65%(+9.7%) |
| Dec 2020 | 78.50%(+7.8%) | 81.69%(+0.6%) |
| Sep 2020 | - | 81.18%(+21.4%) |
| Jun 2020 | - | 66.89%(+1.7%) |
| Mar 2020 | - | 65.79%(-3.2%) |
| Dec 2019 | 72.84%(+42.1%) | 67.96%(+7.0%) |
| Sep 2019 | - | 63.52%(+1.5%) |
| Jun 2019 | - | 62.59%(+8.9%) |
| Mar 2019 | - | 57.50%(+12.5%) |
| Dec 2018 | 51.26%(+89.2%) | 51.11%(+17.4%) |
| Sep 2018 | - | 43.53%(+16.0%) |
| Jun 2018 | - | 37.54%(+18.6%) |
| Mar 2018 | - | 31.66%(+17.9%) |
| Dec 2017 | 27.10%(+40.3%) | 26.85%(+10.0%) |
| Sep 2017 | - | 24.41%(-0.9%) |
| Jun 2017 | - | 24.62%(+17.7%) |
| Mar 2017 | - | 20.92%(+8.1%) |
| Dec 2016 | 19.32%(-18.6%) | 19.36%(-0.6%) |
| Sep 2016 | - | 19.47%(+1.7%) |
| Jun 2016 | - | 19.14%(-15.6%) |
| Mar 2016 | - | 22.67%(-3.0%) |
| Dec 2015 | 23.73%(+61.0%) | 23.38%(+54.0%) |
| Sep 2015 | - | 15.18%(+8.0%) |
| Jun 2015 | - | 14.05%(+8.6%) |
| Mar 2015 | - | 12.94%(-8.9%) |
| Dec 2014 | 14.74%(-41.8%) | 14.20%(-35.6%) |
| Sep 2014 | - | 22.05%(+0.6%) |
| Jun 2014 | - | 21.91%(-5.6%) |
| Mar 2014 | - | 23.22%(-2.6%) |
| Dec 2013 | 25.34%(+31.0%) | 23.85%(+14.1%) |
| Sep 2013 | - | 20.91%(-13.0%) |
| Jun 2013 | - | 24.04%(+16.8%) |
| Mar 2013 | - | 20.58%(+6.0%) |
| Dec 2012 | 19.34%(-24.2%) | 19.41%(-0.4%) |
| Sep 2012 | - | 19.48%(+12.5%) |
| Jun 2012 | - | 17.32%(-19.3%) |
| Mar 2012 | - | 21.47%(-14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | 25.51%(-22.1%) | 25.03%(-11.9%) |
| Sep 2011 | - | 28.41%(-5.7%) |
| Jun 2011 | - | 30.14%(-3.4%) |
| Mar 2011 | - | 31.21%(-2.7%) |
| Dec 2010 | 32.75%(+19.7%) | 32.06%(-2.8%) |
| Sep 2010 | - | 32.99%(+4.5%) |
| Jun 2010 | - | 31.57%(+8.9%) |
| Mar 2010 | - | 29.00%(+11.0%) |
| Dec 2009 | 27.35%(+91.4%) | 26.12%(+16.5%) |
| Sep 2009 | - | 22.43%(+17.7%) |
| Jun 2009 | - | 19.06%(+16.8%) |
| Mar 2009 | - | 16.32%(+17.4%) |
| Dec 2008 | 14.29%(+12.3%) | 13.90%(-6.9%) |
| Sep 2008 | - | 14.93%(+8.8%) |
| Jun 2008 | - | 13.72%(+13.1%) |
| Mar 2008 | - | 12.13%(-5.2%) |
| Dec 2007 | 12.72%(-37.5%) | 12.79%(+8.8%) |
| Sep 2007 | - | 11.76%(-16.3%) |
| Jun 2007 | - | 14.05%(-16.2%) |
| Mar 2007 | - | 16.76%(-11.0%) |
| Dec 2006 | 20.35%(+53.8%) | 18.84%(-17.1%) |
| Sep 2006 | - | 22.73%(+11.6%) |
| Jun 2006 | - | 20.36%(+11.7%) |
| Mar 2006 | - | 18.22%(+37.5%) |
| Dec 2005 | 13.23%(+37.4%) | 13.25%(+38.0%) |
| Sep 2005 | - | 9.60%(+10.2%) |
| Jun 2005 | - | 8.71%(+1.9%) |
| Mar 2005 | - | 8.55%(-10.7%) |
| Dec 2004 | 9.63%(-54.7%) | 9.57%(-22.3%) |
| Sep 2004 | - | 12.31%(-17.2%) |
| Jun 2004 | - | 14.87%(-12.2%) |
| Mar 2004 | - | 16.94%(-26.2%) |
| Dec 2003 | 21.28%(-67.1%) | 22.94%(-11.8%) |
| Sep 2003 | - | 26.02%(-51.6%) |
| Jun 2003 | - | 53.78%(-20.0%) |
| Mar 2003 | - | 67.25%(+2.2%) |
| Dec 2002 | 64.64%(+106.0%) | 65.82%(-13.7%) |
| Sep 2002 | - | 76.29%(+77.3%) |
| Jun 2002 | - | 43.02%(+57.3%) |
| Mar 2002 | - | 27.35%(-17.8%) |
| Dec 2001 | 31.38%(-88.0%) | 33.26%(-58.9%) |
| Sep 2001 | - | 80.99%(-18.6%) |
| Jun 2001 | - | 99.45%(-21.5%) |
| Mar 2001 | - | 126.63%(-11.9%) |
| Dec 2000 | 261.38%(-179.2%) | 143.74%(-1933.4%) |
| Sep 2000 | - | -7.84%(-110.7%) |
| Jun 2000 | - | 73.34%(+54.1%) |
| Mar 2000 | - | 47.60% |
| Dec 1999 | -330.09%(+624.0%) | - |
| Dec 1998 | -45.59%(-53.2%) | - |
| Dec 1997 | -97.42%(-1797.2%) | - |
| Dec 1996 | 5.74% | - |
FAQ
- What is Medifast annual return on equity?
- What is the all time high annual ROE for Medifast?
- What is Medifast annual ROE year-on-year change?
- What is Medifast quarterly return on equity?
- What is the all time high quarterly ROE for Medifast?
- What is Medifast quarterly ROE year-on-year change?
What is Medifast annual return on equity?
The current annual ROE of MED is 55.77%
What is the all time high annual ROE for Medifast?
Medifast all-time high annual return on equity is 261.38%
What is Medifast annual ROE year-on-year change?
Over the past year, MED annual return on equity has changed by -24.54% (-30.56%)
What is Medifast quarterly return on equity?
The current quarterly ROE of MED is 3.60%
What is the all time high quarterly ROE for Medifast?
Medifast all-time high quarterly return on equity is 143.74%
What is Medifast quarterly ROE year-on-year change?
Over the past year, MED quarterly return on equity has changed by -11.12% (-75.54%)